ID   NB5R4_RAT               Reviewed;         520 AA.
AC   Q68EJ0; Q6VXY2; Q6VXY3; Q9EPZ4;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   15-MAY-2007, sequence version 2.
DT   02-OCT-2024, entry version 136.
DE   RecName: Full=Cytochrome b5 reductase 4;
DE            EC=1.6.2.2;
DE   AltName: Full=Flavohemoprotein b5/b5R;
DE            Short=b5+b5R;
DE   AltName: Full=N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein;
DE   AltName: Full=cb5/cb5R;
GN   Name=Cyb5r4; Synonyms=Ncb5or;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 35-520 (ISOFORM 1), ENZYME ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, FAD-BINDING, HEME-BINDING AT HIS-89 AND
RP   HIS-112, AND MUTAGENESIS OF HIS-89 AND HIS-112.
RX   PubMed=11913972; DOI=10.1006/abbi.2002.2783;
RA   Davis C.A., Dhawan I.K., Johnson M.K., Barber M.J.;
RT   "Heterologous expression of an endogenous rat cytochrome b(5)/cytochrome
RT   b(5) reductase fusion protein: identification of histidines 62 and 85 as
RT   the heme axial ligands.";
RL   Arch. Biochem. Biophys. 400:63-75(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 35-520 (ISOFORMS 1 AND 2), AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Testis;
RX   PubMed=14962668; DOI=10.1016/j.ygeno.2003.08.020;
RA   Curry B.J., Roman S.D., Wallace C.A., Scott R., Miriami E., Aitken R.J.;
RT   "Identification and characterization of a novel splice variant of mouse and
RT   rat cytochrome b5/cytochrome b5 reductase.";
RL   Genomics 83:425-438(2004).
CC   -!- FUNCTION: NADH-cytochrome b5 reductase involved in endoplasmic
CC       reticulum stress response pathway. Plays a critical role in protecting
CC       pancreatic beta-cells against oxidant stress, possibly by protecting
CC       the cell from excess buildup of reactive oxygen species (ROS).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 Fe(III)-[cytochrome b5] + NADH = 2 Fe(II)-[cytochrome b5] +
CC         H(+) + NAD(+); Xref=Rhea:RHEA:46680, Rhea:RHEA-COMP:10438, Rhea:RHEA-
CC         COMP:10439, ChEBI:CHEBI:15378, ChEBI:CHEBI:29033, ChEBI:CHEBI:29034,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.6.2.2;
CC         Evidence={ECO:0000269|PubMed:11913972};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:11913972};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=28 uM for ferricyanide {ECO:0000269|PubMed:11913972};
CC         KM=1 uM for NADPH {ECO:0000269|PubMed:11913972};
CC         KM=7 uM for cytochrome c {ECO:0000269|PubMed:11913972};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum. Note=Soluble protein.
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q68EJ0-1; Sequence=Displayed;
CC       Name=2; Synonyms=cb5/cb5rDelta12;
CC         IsoId=Q68EJ0-2; Sequence=VSP_025563;
CC   -!- TISSUE SPECIFICITY: Isoform 2 is expressed in testis, brain, skeletal
CC       muscle and in the male germline. {ECO:0000269|PubMed:14962668}.
CC   -!- SIMILARITY: Belongs to the flavoprotein pyridine nucleotide cytochrome
CC       reductase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH80240.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC080240; AAH80240.1; ALT_INIT; mRNA.
DR   EMBL; AF307840; AAG45053.1; -; mRNA.
DR   EMBL; AY321370; AAQ83902.1; -; mRNA.
DR   EMBL; AY321371; AAQ83903.1; -; mRNA.
DR   RefSeq; NP_596918.3; NM_133427.3.
DR   AlphaFoldDB; Q68EJ0; -.
DR   SMR; Q68EJ0; -.
DR   STRING; 10116.ENSRNOP00000013909; -.
DR   PhosphoSitePlus; Q68EJ0; -.
DR   jPOST; Q68EJ0; -.
DR   PaxDb; 10116-ENSRNOP00000013909; -.
DR   GeneID; 171015; -.
DR   KEGG; rno:171015; -.
DR   UCSC; RGD:621834; rat. [Q68EJ0-1]
DR   AGR; RGD:621834; -.
DR   CTD; 51167; -.
DR   RGD; 621834; Cyb5r4.
DR   eggNOG; KOG0534; Eukaryota.
DR   eggNOG; KOG0536; Eukaryota.
DR   InParanoid; Q68EJ0; -.
DR   OrthoDB; 163533at2759; -.
DR   PhylomeDB; Q68EJ0; -.
DR   BRENDA; 1.6.2.2; 5301.
DR   Reactome; R-RNO-1237044; Erythrocytes take up carbon dioxide and release oxygen.
DR   SABIO-RK; Q68EJ0; -.
DR   PRO; PR:Q68EJ0; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0004128; F:cytochrome-b5 reductase activity, acting on NAD(P)H; ISO:RGD.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:RGD.
DR   GO; GO:0020037; F:heme binding; IDA:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016174; F:NAD(P)H oxidase H2O2-forming activity; ISO:RGD.
DR   GO; GO:0003958; F:NADPH-hemoprotein reductase activity; IDA:RGD.
DR   GO; GO:0016653; F:oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor; ISO:RGD.
DR   GO; GO:0048468; P:cell development; ISO:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0030073; P:insulin secretion; ISO:RGD.
DR   GO; GO:0006739; P:NADP metabolic process; IDA:RGD.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; ISO:RGD.
DR   GO; GO:0046677; P:response to antibiotic; ISO:RGD.
DR   GO; GO:0006801; P:superoxide metabolic process; ISO:RGD.
DR   CDD; cd06183; cyt_b5_reduct_like; 1.
DR   CDD; cd06490; p23_NCB5OR; 1.
DR   Gene3D; 2.60.40.790; -; 1.
DR   Gene3D; 3.10.120.10; Cytochrome b5-like heme/steroid binding domain; 1.
DR   Gene3D; 3.40.50.80; Nucleotide-binding domain of ferredoxin-NADP reductase (FNR) module; 1.
DR   Gene3D; 2.40.30.10; Translation factors; 1.
DR   InterPro; IPR001834; CBR-like.
DR   InterPro; IPR008333; Cbr1-like_FAD-bd_dom.
DR   InterPro; IPR007052; CS_dom.
DR   InterPro; IPR001199; Cyt_B5-like_heme/steroid-bd.
DR   InterPro; IPR036400; Cyt_B5-like_heme/steroid_sf.
DR   InterPro; IPR018506; Cyt_B5_heme-BS.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR008978; HSP20-like_chaperone.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR037908; p23_NCB5OR.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   PANTHER; PTHR19370; NADH-CYTOCHROME B5 REDUCTASE; 1.
DR   PANTHER; PTHR19370:SF185; NADH-CYTOCHROME B5 REDUCTASE 2; 1.
DR   Pfam; PF04969; CS; 1.
DR   Pfam; PF00173; Cyt-b5; 1.
DR   Pfam; PF00970; FAD_binding_6; 1.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   PRINTS; PR00406; CYTB5RDTASE.
DR   PRINTS; PR00363; CYTOCHROMEB5.
DR   SMART; SM01117; Cyt-b5; 1.
DR   SUPFAM; SSF55856; Cytochrome b5-like heme/steroid binding domain; 1.
DR   SUPFAM; SSF52343; Ferredoxin reductase-like, C-terminal NADP-linked domain; 1.
DR   SUPFAM; SSF49764; HSP20-like chaperones; 1.
DR   SUPFAM; SSF63380; Riboflavin synthase domain-like; 1.
DR   PROSITE; PS51203; CS; 1.
DR   PROSITE; PS00191; CYTOCHROME_B5_1; 1.
DR   PROSITE; PS50255; CYTOCHROME_B5_2; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Endoplasmic reticulum; FAD;
KW   Flavoprotein; Heme; Iron; Metal-binding; NAD; Oxidoreductase;
KW   Reference proteome.
FT   CHAIN           1..520
FT                   /note="Cytochrome b5 reductase 4"
FT                   /id="PRO_0000287558"
FT   DOMAIN          54..130
FT                   /note="Cytochrome b5 heme-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00279"
FT   DOMAIN          164..255
FT                   /note="CS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00547"
FT   DOMAIN          272..384
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   REGION          1..27
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         89
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT   BINDING         112
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT   BINDING         364..379
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250"
FT   BINDING         391..423
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7L1T6"
FT   VAR_SEQ         318..368
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14962668"
FT                   /id="VSP_025563"
FT   MUTAGEN         89
FT                   /note="H->A,M: Abolishes heme-binding but does not affect
FT                   reductase activity."
FT                   /evidence="ECO:0000269|PubMed:11913972"
FT   MUTAGEN         112
FT                   /note="H->A,M: Abolishes heme-binding but does not affect
FT                   reductase activity."
FT                   /evidence="ECO:0000269|PubMed:11913972"
FT   CONFLICT        38
FT                   /note="F -> I (in Ref. 1; AAH80240)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        244
FT                   /note="Q -> L (in Ref. 2; AAG45053)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   520 AA;  58835 MW;  F0C0553206F7976A CRC64;
     MLNVPSQAFP APGSQQRVAS QGRSKVPLKQ GRSLMDWFRL TKSGKDFTGL KGGLIEVTEE
     ELKKHNKKDD CWICIRGFVY NVSPYMEYHP GGEDELMRAA GADGTDLFNE VHRWVNYESM
     LKECLVGRMA VKPAVPKDCH EGKRVLNGML PKSQVTDTLP REGPSSPSYD WFQTESSVTI
     VIYTKQKNIN LDSVIVDLQD DSLRAEAVIK DHSYLIHIGL SHEVQENFSV RVIENVGKIE
     IVLQKKETVS WKCLGDPLEK HDSFIPKKDT GLYYRQCQLI SKEDVTHDTR LFCLMLPPST
     HLQVPVGQHV YLKLSVTGAE IVKPYTPVSE SLLSDFKEPV LSPNKYIYFL IKIYPAGLFT
     PELDRLQIGD FVSVSGPEGN FKVSKLQEVE DLFLLAAGTG FTPMVTVLNH ALTHMSSLRK
     VKLMFFNKTE DDIIWRCQLE KLALKDKRFH VEYVLSAPSP EWNGKQGHVS RALLSEFLQR
     SLENSKVFLC ICGPTPFTDE GIRLLHDLNF SDDEIHGFTA
//
